OptimizeRx Corporation (OPRX)
NASDAQ: OPRX · Real-Time Price · USD
18.07
-0.16 (-0.88%)
At close: Aug 29, 2025, 4:00 PM
18.53
+0.46 (2.55%)
After-hours: Aug 29, 2025, 7:10 PM EDT
OptimizeRx Market Cap
OptimizeRx has a market cap or net worth of $335.47 million as of August 29, 2025. Its market cap has increased by 119.69% in one year.
Market Cap
335.47M
Enterprise Value
347.86M
1-Year Change
119.69%
Ranking
Category
Stock Price
$18.07
Market Cap Chart
Since June 22, 2018, OptimizeRx's market cap has increased from $34.20M to $335.47M, an increase of 880.91%. That is a compound annual growth rate of 37.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 29, 2025 | 335.50M | 274.86% |
| Dec 31, 2024 | 89.50M | -65.55% |
| Dec 29, 2023 | 259.80M | -9.85% |
| Dec 30, 2022 | 288.20M | -73.89% |
| Dec 31, 2021 | 1.10B | 134.43% |
| Dec 31, 2020 | 470.80M | 223.35% |
| Dec 31, 2019 | 145.60M | 10.47% |
| Dec 31, 2018 | 131.80M | 285.38% |
| Jun 22, 2018 | 34.20M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 657.66B |
| Johnson & Johnson | 426.69B |
| AbbVie | 371.68B |
| UnitedHealth Group | 280.64B |
| Novo Nordisk | 249.87B |
| AstraZeneca | 246.96B |
| Novartis AG | 244.78B |
| Abbott Laboratories | 230.89B |